Published in Am J Cardiol on May 01, 1999
The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet (1999) 4.77
Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol (1998) 2.19
Endoscopic closure of esophageal intrathoracic leaks: stent versus endoscopic vacuum-assisted closure, a retrospective analysis. Endoscopy (2013) 2.08
PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature (1997) 2.08
Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris. Acute results and incidence of restenosis during 6-month follow-up. Circulation (1990) 2.05
Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics (2001) 1.91
Visualization of coronary artery anomalies and their anatomic course by contrast-enhanced electron beam tomography and three-dimensional reconstruction. Am J Cardiol (2001) 1.89
PTCA registry of German community hospitals. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) Study Group. Eur Heart J (1997) 1.69
The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart (2010) 1.64
The safety and efficacy of an extravascular, water-soluble sealant for vascular closure: initial clinical results for Mynx. Catheter Cardiovasc Interv (2007) 1.63
Pseudoaneurysm after cardiac catheterization: therapeutic interventions and their sequelae: experience in 86 patients. Cathet Cardiovasc Diagn (1997) 1.62
Extent, determinants and clinical importance of pressure recovery in patients with aortic valve stenosis. Eur Heart J (1999) 1.54
Smooth muscle cell proliferation and restenosis after stand alone coronary excimer laser angioplasty. J Am Coll Cardiol (1991) 1.50
The impact of untreated coronary dissections on acute and long-term outcome after intravascular ultrasound guided PTCA. Eur Heart J (2000) 1.45
Local drug delivery: impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wall. Catheter Cardiovasc Interv (1999) 1.44
The patient with acute myocardial infarction who does not receive reperfusion treatment. Heart (2001) 1.43
The 60 Minutes Myocardial Infarction Project. Characteristics on admission and clinical outcome in patients with reinfarction compared to patients with a first infarction. Eur Heart J (1998) 1.42
Non-invasive magnetic resonance imaging of coronary bypass grafts. comparison of the haste- and navigator techniques with conventional coronary angiography. Int J Cardiovasc Imaging (2002) 1.41
Importance of calibration for diameter and area determination by intravascular ultrasound. Int J Card Imaging (1996) 1.41
Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery disease. Blood Coagul Fibrinolysis (2002) 1.41
Local drug delivery via transvascular injection. J Invasive Cardiol (1999) 1.40
Local and systemic delivery of low molecular weight heparin following PTCA: acute results and 6-month follow-up of the initial clinical experience with the porous balloon (PILOT-study). Preliminary Investigation of Local Therapy Using Porous PTCA Balloons. Cathet Cardiovasc Diagn (1998) 1.40
[Prospective feasibility study of chest X-ray vs. thoracic MRI in breath-hold technique at an open low-field scanner]. Rofo (2002) 1.39
[Long-term therapy after an acute myocardial infarct]. Dtsch Med Wochenschr (1992) 1.39
Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Catheter Cardiovasc Interv (1999) 1.39
[Diagnosis of pulmonary embolism]. Dtsch Med Wochenschr (1996) 1.38
"Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry. Z Kardiol (2004) 1.28
Assessment of left ventricular function and mass in patients undergoing computed tomography (CT) coronary angiography using 64-detector-row CT: comparison to magnetic resonance imaging. Acta Radiol (2007) 1.17
Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J (1984) 1.14
Mammalian skeletal muscle: reduced chloride conductance in drug-induced myotonia and induction of myotonia by low-chloride solution. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.10
[Policy paper to the cardiac re-sychronization therapy]. Z Kardiol (2003) 1.09
[Gangrene following erroneous intra-arterial injection of dicloxacillin]. Dtsch Med Wochenschr (1971) 1.08
Polytopic anomalies with agenesis of the lower vertebral column. Am J Med Genet (1999) 1.06
Presynaptic depolarization of cutaneous mechanoreceptor afferents after mechanical skin stimulation. Exp Brain Res (1967) 1.05
Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol (2014) 1.04
Acute myocardial infarction occurring in versus out of the hospital: patient characteristics and clinical outcome. Maximal Individual TheRapy in Acute Myocardial Infarction (MITRA) Study Group. J Am Coll Cardiol (2000) 1.03
Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation (2000) 1.03
Worldwide utilization of implantable cardioverter/defibrillators now and in the future. Card Electrophysiol Rev (2003) 1.00
Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis. Am Heart J (2001) 1.00
BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families. Clin Genet (2011) 0.99
Quantitative and qualitative assay of amniotic-fluid acetylcholinesterase in the prenatal diagnosis of neural tube defects. Hum Genet (1981) 0.99
The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry. Clin Res Cardiol (2007) 0.98
Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator. Am J Cardiol (1998) 0.98
[Lead-related complications in 340 patients with an implantable cardiverter/defibrillator]. Z Kardiol (1999) 0.98
Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis. Z Kardiol (2004) 0.97
125th anniversary of the Institute of Neurology (Obersteiner Institute) in Vienna. "Germ Cell" of interdisciplinary neuroscience. Clin Neuropathol (2009) 0.96
Intravascular electric impedance spectroscopy of atherosclerotic lesions using a new impedance catheter system. Basic Res Cardiol (2005) 0.95
Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system. J Cardiovasc Electrophysiol (2001) 0.95
Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded murine tissue. Am J Pathol (2001) 0.93
Visualization and comparison of drug effects after local paclitaxel delivery with different catheter types. Basic Res Cardiol (1999) 0.92